Ajo LP purchased a new position in shares of Boston Scientific Corporation (NYSE:BSX) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 28,244 shares of the medical equipment provider’s stock, valued at approximately $783,000.

A number of other institutional investors have also recently added to or reduced their stakes in BSX. UBS Asset Management Americas Inc. boosted its holdings in Boston Scientific Corporation by 9.1% during the first quarter. UBS Asset Management Americas Inc. now owns 3,435,806 shares of the medical equipment provider’s stock worth $85,448,000 after purchasing an additional 286,705 shares during the last quarter. Commerce Bank purchased a new position in Boston Scientific Corporation in the first quarter valued at about $207,000. Quantitative Investment Management LLC boosted its stake in Boston Scientific Corporation by 210.0% in the first quarter. Quantitative Investment Management LLC now owns 947,200 shares of the medical equipment provider’s stock valued at $23,556,000 after acquiring an additional 641,700 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp boosted its stake in Boston Scientific Corporation by 1.0% in the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 2,766,481 shares of the medical equipment provider’s stock valued at $68,802,000 after acquiring an additional 27,551 shares during the last quarter. Finally, Keybank National Association OH boosted its stake in Boston Scientific Corporation by 11.4% in the first quarter. Keybank National Association OH now owns 27,475 shares of the medical equipment provider’s stock valued at $683,000 after acquiring an additional 2,805 shares during the last quarter. Institutional investors and hedge funds own 90.44% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was originally published by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/09/21/ajo-lp-purchases-shares-of-28244-boston-scientific-corporation-bsx.html.

BSX has been the topic of several research reports. Jefferies Group LLC reissued a “hold” rating on shares of Boston Scientific Corporation in a research report on Thursday, September 7th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $31.00 target price on shares of Boston Scientific Corporation in a report on Friday, September 1st. BidaskClub lowered shares of Boston Scientific Corporation from a “hold” rating to a “sell” rating in a report on Saturday, August 26th. Oppenheimer Holdings, Inc. reaffirmed a “hold” rating on shares of Boston Scientific Corporation in a report on Wednesday, August 9th. Finally, UBS AG reaffirmed a “buy” rating and set a $31.00 target price (up previously from $30.00) on shares of Boston Scientific Corporation in a report on Tuesday, August 1st. One investment analyst has rated the stock with a sell rating, five have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Boston Scientific Corporation presently has an average rating of “Buy” and an average target price of $29.88.

In other news, SVP Wendy Carruthers sold 12,433 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $26.75, for a total transaction of $332,582.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael P. Phalen sold 15,500 shares of the business’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $28.02, for a total transaction of $434,310.00. The disclosure for this sale can be found here. Insiders have sold 275,257 shares of company stock valued at $7,512,394 over the last three months. Insiders own 0.74% of the company’s stock.

Boston Scientific Corporation (NYSE BSX) opened at 28.84 on Thursday. The firm has a 50-day moving average of $27.39 and a 200 day moving average of $26.61. Boston Scientific Corporation has a one year low of $19.67 and a one year high of $29.40. The company has a market capitalization of $39.57 billion, a price-to-earnings ratio of 51.59 and a beta of 1.09.

Boston Scientific Corporation (NYSE:BSX) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $0.32 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.01. The firm had revenue of $2.26 billion during the quarter, compared to analyst estimates of $2.21 billion. Boston Scientific Corporation had a net margin of 9.04% and a return on equity of 23.62%. The business’s revenue was up 6.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.27 earnings per share. Equities research analysts predict that Boston Scientific Corporation will post $1.26 earnings per share for the current fiscal year.

Boston Scientific Corporation Company Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Institutional Ownership by Quarter for Boston Scientific Corporation (NYSE:BSX)

Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.